<div dir="ltr"><div class="gmail_default" style="font-family:comic sans ms,sans-serif;font-size:large;color:#000000">Yes, but medical marijuana has the THC taken out of it - no highs. LSD and the rest are unaltered, as I understand it, and people will get high or whatever you want to call it, and many conservatives will have big problems with that. bill w</div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Fri, Apr 16, 2021 at 11:03 AM Nuala Thomson via extropy-chat <<a href="mailto:extropy-chat@lists.extropy.org">extropy-chat@lists.extropy.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="auto">They can't patent it but if medicinal marijuana can get passed then I don't see why this can't, except they have to spend money and roll out an approval system. Obviously costing a lot to hire the right people, federal courts, FDA, etc. Etc.</div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Sat., Apr. 17, 2021, 00:55 William Flynn Wallace via extropy-chat, <<a href="mailto:extropy-chat@lists.extropy.org" target="_blank">extropy-chat@lists.extropy.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="ltr"><div class="gmail_default" style="font-family:"comic sans ms",sans-serif;font-size:large;color:rgb(0,0,0)">Here's the problem: only Big PHarma has the money, often billions needed, to fully test a drug and get FDA approval, and they are not going to do that for this type of drug -can't make any money from it - can't patent it, etc. bill w</div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Fri, Apr 16, 2021 at 9:47 AM Nuala Thomson via extropy-chat <<a href="mailto:extropy-chat@lists.extropy.org" rel="noreferrer" target="_blank">extropy-chat@lists.extropy.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="auto">Micro dosing has been around for ages. I think LSD yields similar results and micro dosing mdma has helped couples/marriages.<div dir="auto">The problem is getting this sort of therapy approved as mainstream and more providers able to administer it.</div><div dir="auto">Regardless, I'm definitely not adverse to a "reset" once or twice a year.</div><div dir="auto">I think it's beneficial even outside of a therapy session as I find it helps with my own spirituality and exploration.</div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Fri., Apr. 16, 2021, 21:57 John Grigg via extropy-chat, <<a href="mailto:extropy-chat@lists.extropy.org" rel="noreferrer" target="_blank">extropy-chat@lists.extropy.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir="ltr"><div>
<p><font size="4">"Psilocybin, the hallucinogen found in "magic mushrooms," may work
just as well as a common antidepressant drug at treating symptoms of
depression, a small new study suggests.</font></p><p><font size="4">The study found that people who took psilocybin twice under the supervision of psychiatrists showed similar reductions in <a href="https://www.livescience.com/34718-depression-treatment-psychotherapy-anti-depressants.html" rel="noreferrer noreferrer" target="_blank"><u>depression</u></a>
symptoms — based on scores on a survey — compared with people who took a
six-week course of the antidepressant escitalopram. And those in the
psilocybin group were more likely to report remission from depression
symptoms, compared with those in the escitalopram group, according to
the study, published Wednesday (April 14) in <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa2032994" rel="noreferrer noreferrer" target="_blank"><u>The New England Journal of Medicine</u></a>.</font></p><p><font size="4">"One
of the most important aspects of this work is that people can clearly
see the promise of properly delivered psilocybin therapy by viewing it
compared with a more familiar, established treatment in the same study,"
study lead author Robin Carhart-Harris, head of the Centre for
Psychedelic Research at Imperial College London, <a href="https://www.eurekalert.org/emb_releases/2021-04/icl-mmc041321.php" rel="noreferrer noreferrer" target="_blank"><u>said in a statement</u></a>. "Psilocybin performed very favourably in this head-to-head [trial]."</font></p><font size="4">
</font></div><div><font size="4"><br></font></div><div><font size="4"><a href="https://www.livescience.com/psilocybin-versus-antidepressants-magic-mushrooms.html" rel="noreferrer noreferrer" target="_blank">https://www.livescience.com/psilocybin-versus-antidepressants-magic-mushrooms.html</a></font></div></div>
_______________________________________________<br>
extropy-chat mailing list<br>
<a href="mailto:extropy-chat@lists.extropy.org" rel="noreferrer noreferrer" target="_blank">extropy-chat@lists.extropy.org</a><br>
<a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
</blockquote></div>
_______________________________________________<br>
extropy-chat mailing list<br>
<a href="mailto:extropy-chat@lists.extropy.org" rel="noreferrer" target="_blank">extropy-chat@lists.extropy.org</a><br>
<a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
</blockquote></div>
_______________________________________________<br>
extropy-chat mailing list<br>
<a href="mailto:extropy-chat@lists.extropy.org" rel="noreferrer" target="_blank">extropy-chat@lists.extropy.org</a><br>
<a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
</blockquote></div>
_______________________________________________<br>
extropy-chat mailing list<br>
<a href="mailto:extropy-chat@lists.extropy.org" target="_blank">extropy-chat@lists.extropy.org</a><br>
<a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
</blockquote></div>